| Opella Healthcare Switzerland AG - Laxoberon, Tropfen zum Einnehmen, Lösung |
| 37871 | | 02 | | Laxoberon | | Tropfen zum Einnehmen, Lösung | | A06AB08 | | Sodium Picosulfate | | 25.07.2007 | | |
|
| Composition |
| natrii picosulfas monohydricus 7.5 mg corresp. natrii picosulfas 7.2 mg, sorbitolum liquidum non cristallisabile corresp. sorbitolum 450 mg, natrii benzoas 2 mg, natrii citras dihydricus, acidum citricum monohydricum, aqua purificata ad solutionem pro 1 ml corresp. natrium 1.36 mg corresp. 15 guttae. |
| Packungsbestandteile |
| Tropfen zum Einnehmen | | | | | | | | Active Agent | Dose |
|---|
| Natrii Picosulfas Monohydricus | 7.5 mg/ml correspond Sodium Picosulfate 7.2 mg/ml |
| | BAG: Active Agent | Dose |
|---|
| Sodium Picosulfate Monohydrate | 7.5 mg |
| | | | Inactive agents | Dose |
|---|
| Citric Acid Monohydrate | | | Aqua Purificata | | | Sodium Benzoate | 2 mg/ml | | Natrii Citras Dihydricus | | | Sorbitolum Liquidum non Cristallisabile | |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 052 | 15 ml | PR | PR | D | | Yes | | 060 | 30 ml | 6.28 | 16.05 | B | SL | Yes |
|
